Skip to main content

Published locations for HER2-negative breast cancer: Adjuvant celecoxib fails phase 3 trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2-negative breast cancer: Adjuvant celecoxib fails phase 3 trial

User login

  • Reset your password
  • /content/her2-negative-breast-cancer-adjuvant-celecoxib-fails-phase-3-trial
  • /hematology-oncology/article/245093/breast-cancer/her2-negative-breast-cancer-adjuvant-celecoxib
  • /breast-cancer-icymi/article/245093/breast-cancer/her2-negative-breast-cancer-adjuvant-celecoxib